Patient#	Sample#	GDP:(GTP, active),(RAS family/GDP/Aiolos, active),(RhoA/GDP, active),	Aiolos:(Aiolos, protein),(GTP, active),(RAS family/GDP/Aiolos, active),	ERK1-2:(ERK1-2, protein),	IL2:(IL2, protein),	IL2RA:(IL2RA, protein),	IRS1-2:(IRS1-2, protein),	PPP2R5D:(PPP2R5D, protein),	PTK2B:(PTK2B, protein),	RASA1:(RASA1, protein),	SHC1:(SHC1, protein),	SHP2:(SHP2, protein),	SOCS2:(SOCS2, protein),	STAM1-2:(STAM1-2, protein),	STAT3:(STAT3, protein),	STAT5:(STAT5, protein),	SYK:(SYK, protein),	p38alpha-beta:(p38alpha-beta, protein),	IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3:(IL2, active),(IL2R beta/JAK1/LCK, active),(IL2R beta/JAK1/LCK/CISH, active),(IL2R beta/JAK1/LCK/SOCS1, active),(IL2R beta/JAK1/LCK/SOCS3, active),(IL2R gamma/JAK3, active),(IL2R gamma/JAK3/SOCS1, active),(IL2RA, active),	IL2/IL2R beta/gamma/JAK1/Fyn/JAK3:(IL2, active),(IL2R beta/JAK1/Fyn, active),(IL2R gamma/JAK3, active),	IL2/IL2R beta/gamma/JAK1/LCK/JAK3:(IL2, active),(IL2R beta/JAK1/LCK, active),(IL2R gamma/JAK3, active),	IL2R beta/JAK1/LCK/SOCS3/SOCS2:(IL2R beta/JAK1/LCK/SOCS3, active),(SOCS2, active),	STAT1:(STAT1, protein),	DOK2:(DOK2, protein),(IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3, active),	IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/IRS1-2:(IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3, active),(IRS1-2, active),	IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/PYK2:(IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3, active),(PTK2B, active),	IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC:(IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3, active),(SHC1, active),	IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/STAM1-2:(IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3, active),(STAM1-2, active),	IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SYK:(IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3, active),(SYK, active),	PRKCB:(IL2/IL2R beta/gamma/JAK1/LCK/JAK3, active),(PRKCB, protein),	PRKCE:(IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3, active),(PRKCE, protein),	RhoA/GTP:(GTP, active),(IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3, active),(RhoA/GDP, active),	STAT1 (dimer):(IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3, active),(STAT1, active),	STAT5 (dimer)-active:(IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3, active),(IL2R beta/JAK1/LCK/SOCS1, active),(IL2R beta/JAK1/LCK/SOCS3, active),(STAT5, active),	positive regulation of cell-cell adhesion:(IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3, active),(PPP2R5D, active),	proteasomal ubiquitin-dependent protein catabolic process:(IL2R beta/JAK1/LCK/SOCS3/SOCS2, active),	BCL2:(BCL2, protein),	IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GRB2/SOS1/GAB2:(GAB2/GRB2/SOS1, active),(IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC, active),	JNK1-2:(IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC, active),(JNK1-2, protein),	PI3K:(IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SYK, active),	RasGAP/Dok-R:(DOK2, active),(RASA1, active),	cell proliferation:(IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/PYK2, active),	p38alpha-beta-active:(IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC, active),(p38alpha-beta, active),(p38alpha-beta-active, protein),	IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/IRS1-2/PI3K:(IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/IRS1-2, active),(PI3K, active),	IL2/IL2R beta/gamma/JAK1/Fyn/JAK3/PI3K:(IL2/IL2R beta/gamma/JAK1/Fyn/JAK3, active),(PI3K, active),	IL2/IL2R beta/gamma/JAK1/LCK/JAK3/PI3K:(IL2/IL2R beta/gamma/JAK1/LCK/JAK3, active),(PI3K, active),	MAPKAPK2:(MAPKAPK2, protein),(p38alpha-beta-active, active),	SOCS3:(IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3, active),(SOCS3, protein),	T cell proliferation:(PRKCB, active),(PRKCE, active),(p38alpha-beta-active, active),	MYC:(MYC, protein),	SOCS3/RasGAP:(RASA1, active),(SOCS3, active),	RAS family/GTP:(GTP, active),(IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GRB2/SOS1/GAB2, active),(RAS family/GDP/Aiolos, active),(RasGAP/Dok-R, active),(SOCS3/RasGAP, active),	RAF1:(RAF1, protein),(RAS family/GTP, active),	CDK2	G1/S transition of mitotic cell cycle:(CDK2, active),	ERK1-2-active	IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GRB2/SOS1/GAB2/ERK1-2:(ERK1-2-active, active),(IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GRB2/SOS1/GAB2, active),(SHP2, active),	natural killer cell mediated cytotoxicity:(ERK1-2-active, active),	IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GRB2/SOS1/GAB2/SHP2:(ERK1-2-active, active),(IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GRB2/SOS1/GAB2, active),(SHP2, active),	FOS:(FOS, protein),	IFNG:(IFNG, protein),	IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GAB2/GRB2/SOS1/SHP2/PI3K:(IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GRB2/SOS1/GAB2/SHP2, active),(PI3K, active),(RhoA/GTP, active),	JUN:(JUN, protein),	MEK1-2:(IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3/SHC/GAB2/GRB2/SOS1/SHP2/PI3K, active),(MEK1-2, protein),(RAF1, active),	STAT3 (dimer):(IL2/IL2R alpha/beta/gamma/JAK1/LCK/JAK3, active),(MEK1-2, active),(STAT3, active),	
